Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS・com)

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2013 by Japan Cardiovascular Research Foundation
Sponsor:
Collaborator:
Otsuka Pharmaceutical Co., Ltd.
Information provided by (Responsible Party):
Japan Cardiovascular Research Foundation
ClinicalTrials.gov Identifier:
NCT01995370
First received: November 15, 2013
Last updated: December 3, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2017
  Estimated Primary Completion Date: March 2017 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):